International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation

NACompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

April 30, 2016

Conditions
Lung Preservation
Interventions
DEVICE

OCS Lung

OCS Lung will be used to preserve the donor lungs (Treatment Group).

DEVICE

Cold flush and storage

Donor lungs will preserved using standard cold flush and storage

Trial Locations (21)

2010

St. Vincent's Hospital, Darlinghurst

3000

Hospitals Leuven, Leuven

13915

University Hospitals of Marseille, Marseille

15213

University of Pittsburgh Medical Center, Pittsburgh

20246

Universitäres Herzzentrum Hamburg GmbH, Hamburg

28222

University Puerta de Hierro Hospital, Madrid

35128

University of Padua, Padua

44195

Cleveland Clinic, Cleveland

46202

Indiana University, Indianapolis

55455

University of Minnesota, Minneapolis

67091

N.H.C Hospital Civil, Strasbourg

85013

St. Joseph's Hospital and Medical Center, Phoenix

90095

University of California at Los Angeles, Los Angeles

94143

University of California at San Francisco, San Francisco

02114

Massachusetts General Hospital, Boston

T6G 2C8

University of Alberta, Edmonton

18 eme

Groupe Hospitalier Hopitaux Universitaries, Paris

D-13353

German Heart Institute Berlin, Berlin

D-300625

Hannover Medical School, Hanover

CB23 3 RE

Papworth Hospital, Cambridge

UB9 6JH

Harefield Hospital, Middlesex

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT01630434 - International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation | Biotech Hunter | Biotech Hunter